Tyra biosciences announces participation at upcoming investor events

Carlsbad, calif. , aug. 20, 2025 /prnewswire/ -- tyra biosciences, inc. (nasdaq: tyra), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in fibroblast growth factor receptor (fgfr) biology, announced today that members of company management will participate in the following investor events:           virtual h.c.
TYRA Ratings Summary
TYRA Quant Ranking